Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Achenbach

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
BMC Medicine|May 24, 2023
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetesJean Van Rampelbergh, Peter Achenbach, Richard David Leslie, et al.
BMJ Open|May 20, 2016
Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da studyJennifer Raab, Florian Haupt, Marlon Scholz, et al.
Diabetes Technology & Therapeutics|August 24, 2016
3 Screen ELISA for High-Throughput Detection of Beta Cell Autoantibodies in Capillary BloodAnette-G Ziegler, Florian Haupt, Marlon Scholz, et al.
BMJ Open|November 10, 2021
Supplementation with <i>Bifidobacterium longum</i> subspecies <i>infantis</i> EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocolAnette-Gabriele Ziegler, Stefanie Arnolds, Annika Kölln, et al.
Contemporary Clinical Trials Communications|February 7, 2025
Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocolSandra Hummel, Alexandra Käßl, Stefanie Arnolds, et al.
Diabetes|March 11, 2014
Compromised gut microbiota networks in children with anti-islet cell autoimmunityDavid Endesfelder, Wolfgang zu Castell, Alexandria Ardissone, et al.
Pediatric Diabetes|August 12, 2018
Fasting hypoglycemia is associated with disease progression in presymptomatic early stage type 1 diabetesMelanie Heinrich, Nicole Maison, Peter Achenbach, et al.
The Journal of Clinical Investigation|October 17, 2022
Elevations in blood glucose before and after the appearance of islet autoantibodies in childrenKatharina Warncke, Andreas Weiss, Peter Achenbach, et al.
Diabetes/Metabolism Research and Reviews|February 20, 2024
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetesA Emile J Hendriks, M Loredana Marcovecchio, Rachel E J Besser, et al.
Lancet (London, England)|November 14, 2025
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trialAnette-Gabriele Ziegler, Peter Achenbach, Andreas Weiß, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
BMC Medicine|May 24, 2023
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetesJean Van Rampelbergh, Peter Achenbach, Richard David Leslie, et al.
BMJ Open|May 20, 2016
Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da studyJennifer Raab, Florian Haupt, Marlon Scholz, et al.
Diabetes Technology & Therapeutics|August 24, 2016
3 Screen ELISA for High-Throughput Detection of Beta Cell Autoantibodies in Capillary BloodAnette-G Ziegler, Florian Haupt, Marlon Scholz, et al.
BMJ Open|November 10, 2021
Supplementation with <i>Bifidobacterium longum</i> subspecies <i>infantis</i> EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocolAnette-Gabriele Ziegler, Stefanie Arnolds, Annika Kölln, et al.
Contemporary Clinical Trials Communications|February 7, 2025
Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocolSandra Hummel, Alexandra Käßl, Stefanie Arnolds, et al.
Diabetes|March 11, 2014
Compromised gut microbiota networks in children with anti-islet cell autoimmunityDavid Endesfelder, Wolfgang zu Castell, Alexandria Ardissone, et al.
Pediatric Diabetes|August 12, 2018
Fasting hypoglycemia is associated with disease progression in presymptomatic early stage type 1 diabetesMelanie Heinrich, Nicole Maison, Peter Achenbach, et al.
The Journal of Clinical Investigation|October 17, 2022
Elevations in blood glucose before and after the appearance of islet autoantibodies in childrenKatharina Warncke, Andreas Weiss, Peter Achenbach, et al.
Diabetes/Metabolism Research and Reviews|February 20, 2024
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetesA Emile J Hendriks, M Loredana Marcovecchio, Rachel E J Besser, et al.
Lancet (London, England)|November 14, 2025
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trialAnette-Gabriele Ziegler, Peter Achenbach, Andreas Weiß, et al.
Pageof 11